J Wu, X Zhao, Q Sun, Y Jiang, W Zhang, J Luo… - Biomedicine & …, 2020 - Elsevier
Background Immunotherapy has been shown to be effective as a first-line treatment option
for non-small cell lung cancer (NSCLC) patients. Unfortunately, it has failed to acquire an …